BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ghiringhelli F, Richard C, Chevrier S, Végran F, Boidot R. Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein. World J Gastroenterol 2016; 22(48): 10680-10686 [PMID: 28082821 DOI: 10.3748/wjg.v22.i48.10680]
URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10680.htm
Number Citing Articles
1
AntineoplasticsReactions Weekly 2017; 1644(1): 30 doi: 10.1007/s40278-017-27802-5
2
Su-Jin Koh, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, Ming-Shen Dai, Chuan-Hsun Chang, Tapashi Dalvi, Graham Walker, James Bennett, Joyce O’Shaughnessy, Judith Balmaña. Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT studyBreast Cancer 2022; 29(1): 92 doi: 10.1007/s12282-021-01283-4
3
Jennifer M. J. Jongen, Lizet M. van der Waals, Kari Trumpi, Jamila Laoukili, Niek A. Peters, Susanne J. Schenning-van Schelven, Klaas M. Govaert, Inne H. M. Borel Rinkes, Onno Kranenburg. Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerabilityOncotarget 2017; 8(49): 86296 doi: 10.18632/oncotarget.21145
4
Gloria Ravegnini, Giorgia Valori, Qianqian Zhang, Riccardo Ricci, Patrizia Hrelia, Sabrina Angelini. Pharmacogenetics in the treatment of gastrointestinal stromal tumors – an updated reviewExpert Opinion on Drug Metabolism & Toxicology 2020; 16(9): 797 doi: 10.1080/17425255.2020.1789589
5
Minyi Lee, George Eng, Stephanie R. Barbari, Vikram Deshpande, Polina V. Shcherbakova, Manish K. Gala. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial TumorsClinical and Translational Gastroenterology 2020; 11(3): e00149 doi: 10.14309/ctg.0000000000000149
6
S. Joris, H. Denys, J. Collignon, M. Rasschaert, D. T’Kint de Roodenbeke, F.P. Duhoux, J.-L. Canon, S. Tejpar, J. Mebis, L. Decoster, P. Aftimos, J. De Grève. Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II studyESMO Open 2023; 8(6): 102041 doi: 10.1016/j.esmoop.2023.102041
7
Pedro L.S. Uson, Douglas Riegert-Johnson, Lisa Boardman, John Kisiel, Luke Mountjoy, Neej Patel, Blanca Lizaola-Mayo, Mitesh J. Borad, Daniel Ahn, Mohamad B. Sonbol, Jeremy Jones, Jonathan A. Leighton, Suryakanth Gurudu, Harminder Singh, Margaret Klint, Katie L. Kunze, Michael A. Golafshar, Ed D. Esplin, Robert L. Nussbaum, A. Keith Stewart, Tanio S. Bekaii-Saab, Niloy Jewel Samadder. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective StudyClinical Gastroenterology and Hepatology 2022; 20(3): e508 doi: 10.1016/j.cgh.2021.04.013
8
Minghan Song, Xianrong Zeng, Qian Wu, Jie Huang, Jiayi Dong, Lijuan Shao, Zihao Sun, Yiguang Lin, Size Chen. Metastatic Colorectal Cancer Patient with Microsatellite Stability and Germline BRAC2 Mutation Shows a Complete Response to Olaparib in Combination with a PD-1 Inhibitor and Bevacizumab: A Case Report and Review of the LiteratureLife 2023; 13(5): 1183 doi: 10.3390/life13051183
9
Sandy Chevrier, Corentin Richard, Thomas Collot, Hugo Mananet, Laurent Arnould, Romain Boidot. An Algorithm Combining Patient Performance Status, Second Hit Analysis, PROVEAN and Dann Prediction Tools Could Foretell Sensitization to PARP Inhibitors in Digestive, Skin, Ovarian and Breast CancersCancers 2021; 13(13): 3113 doi: 10.3390/cancers13133113
10
Natalie Y.L. Ngoi, Darwin Tay, Valerie Heong, Yee Liang Thian, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, Sharon Z.L. Koh, David S.P. Tan. Reversal of Bowel Obstruction With Platinum-Based Chemotherapy and Olaparib in Recurrent, Short Platinum-Free Interval, RAD51C Germline Mutation–Associated Ovarian CancerJCO Precision Oncology 2018; (2): 1 doi: 10.1200/PO.18.00008
11
Nicole M. Reilly, Luca Novara, Federica Di Nicolantonio, Alberto Bardelli. Exploiting DNA repair defects in colorectal cancerMolecular Oncology 2019; 13(4): 681 doi: 10.1002/1878-0261.12467
12
Pi-Yueh Chang, Shih-Cheng Chang, Mei-Chia Wang, Jinn-Shiun Chen, Wen-Sy Tsai, Jeng-Fu You, Chia-Chun Chen, Hsiu-Ling Liu, Jy-Ming Chiang. Pathogenic Germline Mutations of DNA Repair Pathway Components in Early-Onset Sporadic Colorectal Polyp and Cancer PatientsCancers 2020; 12(12): 3560 doi: 10.3390/cancers12123560
13
Ryan S. Nelson, Rutika J. Mehta, Howard L. McLeod, Christine M. Walko. Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From ImmunotherapyJCO Precision Oncology 2019; (3): 1 doi: 10.1200/PO.19.00197
14
Pavel Vodicka, Marketa Urbanova, Pavol Makovicky, Kristyna Tomasova, Michal Kroupa, Rudolf Stetina, Alena Opattova, Klara Kostovcikova, Anna Siskova, Michaela Schneiderova, Veronika Vymetalkova, Ludmila Vodickova. Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer PatientsInternational Journal of Molecular Sciences 2020; 21(7): 2473 doi: 10.3390/ijms21072473
15
Georgios I. Papageorgiou, Evangelos Fergadis, Nikos Skouteris, Evridiki Christakos, Sergios A. Tsakatikas, Evangelos Lianos, Christos Kosmas. Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal CancerFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.788809